CNER (CNER) Stock Price & Analysis
CNER (CNER) fell 1.43% to USD 0.01 as of June 10, 2026 at 11:16 UTC, according to Nexqual real-time market data.
CNER last closed at USD 0.01; the session ranged USD 0.01–0.01 on volume of 70,000 shares. Market capitalization is $50.66M, with a 52-week range of USD 0–0.02 (PNK). Source: Nexqual, June 10, 2026 at 11:16 UTC.
Key Statistics (as of June 10, 2026 at 11:16 UTC)
| Price | USD 0.01 |
|---|---|
| Change | ▼ 1.43% (down) |
| Previous Close | USD 0.01 |
| Open | USD 0.01 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0 – 0.02 |
| Volume | 70,000 shares |
| Market Cap | $50.66M |
| Exchange | PNK |
Technical Analysis (CNER)
Nexqual's technical model rates CNER "SELL" based on 2 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 11:16 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 57.26 (neutral) |
| vs SMA50 | Below (USD 0.01) |
| MACD | -0 (negative) |
Analyst Ratings (CNER)
Wall Street analysts rate CNER "None", per Nexqual as of June 10, 2026 at 11:16 UTC.
| Consensus Rating | None |
|---|
Earnings (CNER)
Source: Nexqual, June 10, 2026 at 11:16 UTC.
Financials & Fundamentals (CNER)
| Total Revenue | $12.51M |
|---|---|
| Revenue Growth (YoY) | -85.80% |
| Gross Margin | +73.56% |
| Operating Margin | -871.04% |
| Profit Margin | -96.93% |
| ROE | -112.17% |
| Current Ratio | 0.17 |
| Total Cash | $580,731 |
| Total Debt | $4.26M |
| Free Cash Flow | $40.86M |
Source: Nexqual, June 10, 2026 at 11:16 UTC.
Financial Health Score (CNER)
Nexqual rates CNER's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 11:16 UTC.
| Growth | Critical — Revenue -86% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $581K cash vs $4M debt |
| Cash Flow | Strong — FCF $41M, 327% margin |
| Efficiency | Critical — ROE -112%, ROA 7.6% |
Ownership (CNER)
| Shares Outstanding | 7.34B |
|---|
Source: Nexqual, June 10, 2026 at 11:16 UTC.
Leadership (CNER)
CNER is led by Yang Kan Chong (age 70), Chairman of the Board, Chief Executive Officer and President, per Nexqual as of June 10, 2026 at 11:16 UTC.
| Chairman of the Board, Chief Executive Officer and President | Yang Kan Chong (age 70) |
|---|---|
| Chief Financial Officer, Principal Accounting Officer and Treasurer | Tak Shing Yu AHKSA, Australia (age 57) |
| Chief Operating Officer | Dunhong Shi (age 61) |
| Chief Technology Officer | Changli Li (age 71) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CHHE | China Health Industries Holding | USD 0 | ▲ 0% |
| AOXG | Aoxing Pharmaceutical Company, | USD 0 | ▼ 19.23% |
| GHAV | Grand Havana, Inc. | USD 0 | ▲ 0% |
| CCWF | Church & Crawford, Inc. | USD 0 | ▲ 0% |
| PTOS | P2 Solar, Inc. | USD 0.01 | ▼ 14.55% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 11:16 UTC. This page is informational and not investment advice.